Increased urinary dihydroxyphenylalanine oxidase activity in patients suffering from malignant melanoma.
作者信息
Richterich R, Cantz B, Dauwalder H
出版信息
Clin Chim Acta. 1970 Aug;29(2):295-301. doi: 10.1016/0009-8981(70)90050-1.
PMID:4992734
Abstract
摘要
相似文献
1
Increased urinary dihydroxyphenylalanine oxidase activity in patients suffering from malignant melanoma.
Clin Chim Acta. 1970 Aug;29(2):295-301. doi: 10.1016/0009-8981(70)90050-1.
2
Presence and properties of tyrosinase in sera of melanoma-bearing animals.
Acta Derm Venereol. 1971;51(6):407-12.
3
Physicochemical and kinetic properties of mushroom tyrosinase.
J Biol Chem. 1970 Apr 10;245(7):1613-25.
4
Effect of thiol compounds on melanin formation by tyrosinase.
Biochim Biophys Acta. 1972 Jan 28;261(1):258-66. doi: 10.1016/0304-4165(72)90336-4.
5
3,4-dihydroxy-L-phenylalanine as the tyrosinase cofactor. Occurrence in melanoma and binding constant.
J Biol Chem. 1967 Nov 25;242(22):5308-14.
6
[Inhibition of o-diphenol oxidase activity by borate and germanate].
Hoppe Seylers Z Physiol Chem. 1968 Aug;349(8):982-8.
7
Regulatory mechanisms of tyrosinase activity in melanocyte. I.
Yale J Biol Med. 1973 Dec;46(5):508-15.
8
Widespread occurrence of inhibitors of melanoma tyrosinase in plant and mammalian tissues.
Experientia. 1971 Jun;27(6):644-5. doi: 10.1007/BF02136936.
9
Phenolase of papaver somniferum. I. Isolation of the enzyme and its substrate specificity.
Enzymologia. 1970;39(5):289-306.
10
Intracellular localization of tyrosinase inhibitor in amelanotic and melanotic malignant melanoma.
Br J Dermatol. 1972 Apr;86(4):385-94. doi: 10.1111/j.1365-2133.1972.tb05052.x.
Zotero 插件